Cargando…
STAREE-Mind Imaging Study: a randomised placebo-controlled trial of atorvastatin for prevention of cerebrovascular decline and neurodegeneration in older individuals
INTRODUCTION: Cerebrovascular disease and neurodegeneration are causes of cognitive decline and dementia, for which primary prevention options are currently lacking. Statins are well-tolerated and widely available medications that potentially have neuroprotective effects. The STAREE-Mind Imaging Stu...
Autores principales: | Harding, Ian H, Ryan, Joanne, Heritier, Stephane, Spark, Simone, Flanagan, Zachary, McIntyre, Richard, Anderson, Craig S, Naismith, Sharon L, Chong, Trevor T-J, O'Sullivan, Michael, Egan, Gary, Law, Meng, Zoungas, Sophia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619122/ https://www.ncbi.nlm.nih.gov/pubmed/37920607 http://dx.doi.org/10.1136/bmjno-2023-000541 |
Ejemplares similares
-
Impact of informed consent content and length on recruitment of older adults into a community based primary prevention trial
por: O'Hare, Fleur, et al.
Publicado: (2018) -
Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)
por: Zoungas, Sophia, et al.
Publicado: (2023) -
Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline
por: Bos, Isabelle, et al.
Publicado: (2017) -
How Borexino will stare at the Sun
Publicado: (1998) -
Staring secondaries, where is the primary?
por: Sundaram, P. Shanmuga, et al.
Publicado: (2010)